Canexus Corp (TSE:CUS) had its price objective upped by investment analysts at Raymond James Financial Inc. from C$1.50 to C$1.65 in a research note issued to investors on Thursday. The firm presently has an “outperform” rating on the stock. Raymond James Financial Inc.’s price objective points to a potential upside of 13.01% from the stock’s current price.

Several other brokerages also recently commented on CUS. TD Securities dropped their target price on Canexus Corp from C$1.75 to C$1.40 and set a “hold” rating on the stock in a report on Monday, July 4th. Royal Bank Of Canada dropped their target price on Canexus Corp from C$1.70 to C$1.50 and set a “sector perform” rating on the stock in a report on Tuesday, July 5th. Scotiabank upgraded Canexus Corp from a “tender” rating to a “sector perform” rating and dropped their target price for the company from C$1.40 to C$1.30 in a report on Monday, July 4th. Finally, CIBC reiterated a “sector perform” rating and set a C$1.50 target price on shares of Canexus Corp in a report on Wednesday, July 6th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Canexus Corp presently has a consensus rating of “Hold” and an average target price of C$1.50.

Canexus Corp (TSE:CUS) opened at 1.46 on Thursday. The firm’s market capitalization is $272.86 million. Canexus Corp has a 52-week low of $1.06 and a 52-week high of $1.64. The firm has a 50-day moving average price of $1.26 and a 200 day moving average price of $1.36.

Canexus Corp Company Profile

Canexus Corporation is a Canada-based company engaged in operating North American sodium chlorate production facilities; a North American chlor–alkali production facility, and a sodium chlorate and chlor–alkali production facility. The Company’s segments are North America Sodium Chlorate, North America Chlor–alkali (NACA) and South America (sodium chlorate and chlor–alkali).

Receive News & Ratings for Canexus Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canexus Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.